GRAIL

GRAIL Galleri Consultant ( Clinical Sales - Los Angeles East, CA) #4357

California, United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Medical Devices, DiagnosticsIndustries

Requirements

Candidates must reside within the Los Angeles, CA East Territory, specifically in Pasadena, Burbank, Glendale, Arcadia, or surrounding areas. A market builder mindset with urgency and passion to engage physicians is required. A deep understanding of the Laboratory Developed Test (LDT) market, competitive landscape, and current cancer screening options is necessary.

Responsibilities

The GRAIL Galleri Consultant will execute the go-to-market sales strategy for Galleri by engaging physicians and their staff to integrate MCED technology into office workflows and offer it to appropriate patients. Responsibilities include prospecting and targeting primary care practices, representing the company, collaborating with internal stakeholders, developing and implementing a business plan, meeting or exceeding sales goals, identifying marketplace opportunities, and managing promotional activities. The role involves over 85% in-person visits to targeted physician practices, planning and supporting events, and executing company initiatives.

Skills

Sales
Clinical Sales
Go-to-market strategy
Cancer Screening
MCED technology
Physician Engagement
Healthcare Technology
Next-generation sequencing (NGS)
Computer Science
Data Science
Market Building

GRAIL

Develops blood tests for early cancer detection

About GRAIL

GRAIL focuses on improving cancer detection through advanced blood tests that identify cancer at its earliest stages, enhancing treatment success rates. The company utilizes high-intensity sequencing to analyze tumor genome data, employing algorithms and deep learning to extract actionable information for early cancer detection. GRAIL differentiates itself from competitors by its commitment to large-scale clinical studies that validate the effectiveness of its tests. The primary goal is to reduce global cancer mortality by enabling early diagnosis, making the disease more treatable.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$1,765.5MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Outstanding People - Join a team of passionate and dedicated professionals, committed to collaboration, education, and proactive problem-solving.
Strong Compensation - We offer competitive salaries and savings plans to provide for long-term financial planning.
Complete Health Coverage - Take advantage of comprehensive health coverage, with medical, dental and vision, to keep you and your family healthy.
Work-Life Balance - Make everyday life more manageable with flexible time off – we trust you to do great work and take time for yourself.

Risks

Potential overdiagnosis could impact the perceived value of GRAIL's tests.
Significant net losses may affect investor confidence and long-term sustainability.
High test costs may limit accessibility in markets with less healthcare funding.

Differentiation

GRAIL uses high-intensity sequencing for early cancer detection via blood tests.
The Galleri test screens for over 50 cancers with a single blood draw.
GRAIL's tests are supported by large-scale clinical studies ensuring reliability.

Upsides

Collaborations with platforms like Function Health expand Galleri test accessibility.
Revenue from Galleri grew 52% year-over-year, indicating strong market demand.
GRAIL's technology aligns with trends in personalized and preventative medicine.

Land your dream remote job 3x faster with AI